Loading...
Benefits of introduction of Oncotype DX(®) testing
INTRODUCTION: Decisions regarding adjuvant chemotherapy in women with oestrogen receptor positive, human epidermal growth factor receptor 2 negative, node negative, early invasive breast cancer are unclear. The Recurrence Score(®) (RS) from Oncotype DX(®) (ODX) testing guides decisions based on indi...
Saved in:
| Published in: | Ann R Coll Surg Engl |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Royal College of Surgeons
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6303812/ https://ncbi.nlm.nih.gov/pubmed/30322288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1308/rcsann.2018.0173 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|